by admin | Sep 20, 2022 | News & Opinions
by Tyler Patchen and Kyle LaHucik – EndpointsNews Above image caption: Chaim Lebovits, BrainStorm CEO After a rare public rejection from the FDA last year, BrainStorm Cell Therapeutics is headed back to the regulator with what it claims is a “correction” to...
by admin | Sep 19, 2022 | News & Opinions
by Brian Mattmiller In order to tap the tremendous potential of CRISPR gene editing technology for reversing human disease, Wisconsin scientists are working with a star pupil. The human eye — though one of the body’s most complex and intricate structures — happens to...
by admin | Sep 12, 2022 | News & Opinions
Moderna is suing Pfizer and BioNTech, alleging they copied technology that Moderna first developed years before the pandemic in producing the first COVID-19 vaccine approved in the U.S., the company announced Friday. Driving the news: Moderna is seeking unspecified...
by admin | Sep 11, 2022 | News & Opinions
By Sarah Collins and Jacqueline Garget – University of Cambridge Researchers from the University of Cambridge have created model embryos from mouse stem cells that form a brain, a beating heart, and the foundations of all the other organs of the body – a new...
by admin | Sep 6, 2022 | News & Opinions
Breaking News in #maculardegeneration! First time in USA! Commencement of a Phase 1/2a clinical safety trial using #IPSC stem cells to treat for advanced dry age-related macular degeneration. NIH and #JohnHopkins surgical team implanted a patch of tissue made from...
